Eukarÿs has developed C3P3 RNA polymerase: a patented bioengineered enzyme which demultiplies biomedicines upstream production yields in mammalian cells 
- cost reduction
- ability to produce hard-to-express medicines
- universal: any antibody, recombinant protein, VLP...
- no investment in new equipments
- compatible with all existing technologies
- no impact on biologic quality: glycosylation, folding...

Full freedom to operate

World-class Awards: Prix Galien, Sanofi Golden Ticket

9 publications: Nucleic Acids Research, Nature scientific reports, Journal of Virology...
3 patent families

Eukarÿs

Org chart

Teams

Offices